Comparative Seizure Outcomes of Vagus Nerve Stimulation, Deep Brain Stimulation, and Their Combination in Lennox–Gastaut Syndrome
Annals of Neurology · 2026
DOI: 10.1002/ana.78308 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Neurology, 2026. Verfasst von Cheng-Yen Kuo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Deep Brain Stimulation, Lennox Gastaut Syndrome, Seizures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
Lennox–Gastaut syndrome (LGS) is a severe treatment‐resistant epilepsy. Although vagus nerve stimulation (VNS) and deep brain stimulation (DBS) are established therapies, comparative data and the impact of dual neuromodulation remain limited. We compared seizure outcomes across VNS, DBS, and combined DBS + VNS therapy in LGS.
Methods
This retrospective cohort study at Mayo Clinic (2005–2024) included LGS patients treated with VNS and/or DBS . Seizure frequency was assessed at 6, 12, and 24 months post‐stimulation. Responder was defined as 50% or more seizure reduction.
Results
Forty patients were included (42% female, median, 150 seizures/month). Eleven patients underwent sequential VNS followed by DBS and contributed data to 2 treatment epochs, yielding 3 treatment groups: VNS alone (n = 29), DBS alone (n = 12), and DBS + VNS (n = 10). At 24 months, median seizure reduction rate was comparable between VNS (50%; 95% confidence interval [ CI], 44–75%) and the overall DBS cohort (59%, 95% CI, 33–86%) ( p = 0.54). However, a significant difference emerged when comparing the 3 treatment arms ( p = 0.027). Specifically, DBS + VNS therapy yielded significantly greater median reduction rate (81%, 95% CI, 60–99%) than DBS alone (43%, 95% CI, 0–58%) ( p adj = 0.027) or VNS alone (50%, 95% CI, 44.4–75.0%) ( p adj = 0.048). Four patients attained sustained seizure freedom above 1 year at last follow‐up.
Interpretation
VNS and DBS provide comparable seizure reduction in LGS over a 2‐year follow‐up period. DBS + VNS was associated with further improvements in seizure reduction in this small, retrospective dataset. This possibility warrants further investigation. ANN NEUROL 2026;100:879–892
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, MN, USA.
- Division of Pediatric Neurology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Cheng-Yen Kuo, Ryan D Nguyen, Lily Wong-Kisiel, Keith Starnes, Nicholas M Gregg, Gregory A Worrell, Brian N Lundstrom
Zitieren
APA
Kuo, C. Y., Singh, R., Sharma, S., Nguyen, R. D., Wong-Kisiel, L., Starnes, K., Gregg, N. M., Van Gompel, J., Miller, K. J., Worrell, G. A., & Lundstrom, B. N. (2026). Comparative Seizure Outcomes of Vagus Nerve Stimulation, Deep Brain Stimulation, and Their Combination in Lennox–Gastaut Syndrome. Annals of Neurology. https://doi.org/10.1002/ana.78308
Vancouver
Kuo CY, Singh R, Sharma S, Nguyen RD, Wong-Kisiel L, Starnes K, et al. Comparative Seizure Outcomes of Vagus Nerve Stimulation, Deep Brain Stimulation, and Their Combination in Lennox–Gastaut Syndrome. Annals of Neurology. 2026. doi:10.1002/ana.78308
BibTeX
@article{Kuo2026,
author = {Kuo, Cheng-Yen and Singh, Raunak and Sharma, Shelja and Nguyen, Ryan D and Wong-Kisiel, Lily and Starnes, Keith and Gregg, Nicholas M and Van Gompel, Jamie and Miller, Kai J and Worrell, Gregory A and Lundstrom, Brian N},
title = {Comparative Seizure Outcomes of Vagus Nerve Stimulation, Deep Brain Stimulation, and Their Combination in Lennox–Gastaut Syndrome},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78308}
}
EUVIMED